Kohl's is deeply undervalued due to massive real estate holdings, with $5-$10 billion in assets largely unrecognized by the market. Short interest is extreme, creating potential for a short squeeze as fundamentals improve and shorts are forced to cover. Kohl's debt concerns are overblown; no major maturities until 2030, and recent SPV moves hint at unlocking hidden asset value.

NEW YORK, NY, July 21, 2025 (GLOBE NEWSWIRE) -- Mercurity Fintech Holding Inc. (NASDAQ: MFH) (“Mercurity” or the “Company”), a leading innovator in digital asset treasury and blockchain-enabled financial infrastructure, today announced that it has entered into securities purchase agreements with institutional investors for the purchase and sale of its ordinary shares (or pre-funded warrants to purchase ordinary shares) and warrants to purchase ordinary shares in a registered direct offering. The offering is intended to support the Company's crypto treasury strategy and its continued development of on-chain financial tools.

An investment must pass two key tests to qualify as a high conviction pick for me. I share my two highest conviction investments right now. I detail why they are my highest conviction investments.

AON's Q2 results are expected to gain on new business growth in Commercial Risk Solutions and Health Solutions businesses, partly offset by escalating compensation and benefits costs.

Block (XYZ) will replace Hess Corp. (HES) in the SPX starting this Wednesday. While the inclusion will likely draw more institutional investors to the fintech company, Marley Kayden points to growth being its biggest headwind.

ATLANTA, July 21, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information about UroGen's business, operations, and prospects, including allegations that: (1) the ENVISION clinical study was not designed to demonstrate substantial evidence of effectiveness of UGN-102 because it lacked a concurrent control arm; (2) as a result, the Company would have difficulty demonstrating that the duration of response endpoint was attributable to UGN-102; (3) UroGen failed to heed …

Watch out, AMC. There's a new meme stock on the market.

Board of Directors Unanimously Recommend Approving Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

GE HealthCare Technologies is one of the leaders in the healthcare sector, with a strong position in the global molecular imaging market. GE HealthCare's Pharmaceutical Diagnostics segment's EBIT was $205 million in Q1 2025, up 15.2% year over year. I expect it to rise to $245 million in Q2, driven by increased sales of Vizamyl, which is used to prescribe anti-amyloid drugs for the treatment of Alzheimer's disease.

Diamondback Energy offers compelling value at 10.5x forward earnings, trading well below its historical average. FANG has a high-quality Permian Basin asset base, robust free cash flow, and a strong commitment to shareholder returns via dividends and buybacks. The company's deep inventory, capital discipline, and investment-grade balance sheet position it to outperform as Permian production matures.

JACKSON, Mich. , July 21, 2025 /PRNewswire/ -- The Board of Directors of CMS Energy has declared a quarterly dividend on the company's common stock.

CHICAGO--(BUSINESS WIRE)--Amrize (NYSE: AMRZ) will publish its second quarter 2025 financial results after the U.S. market closes on Wednesday, August 6, 2025, followed by a webcast to discuss the company's financial results at 9:00 am Eastern Time on Thursday, August 7, 2025. Registration for the Q2 2025 live webcast can be completed at https://amrize-quarterly-results-q2-2025.open-exchange.net/ Amrize's financial results, presentation materials and webcast will be accessible in the events sec.

Spain's BBVA expects the acceptance period for its takeover bid for smaller rival Sabadell to start in early September, rather than at the end of July as initially planned, a spokesperson for BBVA said on Monday.

I detail why buying income machines is such a powerful way to fund a retirement. I share my four favorite income machines. I detail why they are my favorites.

Verizon Communications Inc. surpassed analysts' estimates for second-quarter revenue and raised its profit outlook, buoyed by wireless price increases and recent tax legislation. Verizon CEO Hans Vestberg discusses the results on "Bloomberg Open Interest.

Chris Harvey, head of equity strategy at Wells Fargo, explains why he stuck with his year-end target that sees the S&P 500 rallying past 7,000. -------- More on Bloomberg Television and Markets Like this video?

Nasdaq 100 hits record as Meta, Apple, and Alphabet lift tech stocks. Traders eye strong earnings and bullish US stock market forecasts.

We get into the heart of the Q2 earnings season this week, with more than 400 companies on deck to report results, including 109 S&P 500 members. So far, the Q2 cycle is off to a strong start.

Customer concentration and high interest expenses are likely to have impacted CCI's Q2 results despite its unmatched portfolio of wireless communication infrastructure assets.

Park Aerospace posts strong Q1 results with earnings doubling, driven by defense demand. Despite modest tariff headwinds, the company offers an upbeat outlook for the second quarter.